We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
- Authors
Giglio, Pierre; Dhamne, Megha; Hess, Kenneth R; Gilbert, Mark R; Groves, Morris D; Levin, Victor A; Kang, Sanghee L; Ictech, Sandra E; Liu, Vivien; Colman, Howard; Conrad, Charles A; Loghin, Monica; de Groot, John; Yung, W K Alfred; Puduvalli, Vinay K
- Abstract
Therapeutic options for patients with anaplastic gliomas (AGs) are limited despite better insights into glioma biology. The authors previously reported improved outcome in patients with recurrent glioblastoma treated with thalidomide and irinotecan compared with historical controls. Here, results of the AG arm of the study are reported, using this drug combination.
- Publication
Cancer, 2012, Vol 118, Issue 14, p3599
- ISSN
1097-0142
- Publication type
Journal Article
- DOI
10.1002/cncr.26663